Digital Health Roundup: CES 2023 Highlights; US FDA VR, AR Website; Bayer’s Powers Up On Radiology
Executive Summary
In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb provides highlights from the recent CES 2023 conference in Las Vegas. Reed Miller discusses Abbott’s VR partnership with the Blood Centers for America and Barnaby Pickering highlights Bayer’s jump into medtech with its buyout of Blackford Analysis.
You may also be interested in...
CES 2023: Competition Spikes In Cuffless Blood Pressure Monitoring
In this final roundup of innovative health technologies showcased at CES 2023, Medtech Insight highlights three companies, Biobeat, Conneqt and Valencell, that are developing innovative technologies for cuffless blood pressure monitoring. Biobeat is the first company to receive US FDA clearance for a wearable to monitor blood pressure, but competition looms.
Minute Insight: Drug Giant Bayer Jumps Into Medtech Via AI Acquisition
Bayer has purchased Blackford Analysis and its Blackford Platform, an all-in-one software solution for radiology.
Expert: Cybersecurity Requirements In Omnibus Bill Will Provide Visibility For Industry
New cybersecurity regulations passed as part of the year-end omnibus bill included software bills of materials (SBOMs) which will provide visibility to manufacturers and regulators.